Cardiovascular Effects of Anti-Diabetic Medications in Type 2 Diabetes Mellitus

被引:0
|
作者
Samar Singh
Jyoti Bhat
Ping H. Wang
机构
[1] University of California,Center for Diabetes Research and Treatment and Departments of Medicine, Biological Chemistry, Physiology and Biophysics
来源
关键词
Type 2 diabetes; Medications; Side effects; Oral agents; Heart; Cardiovascular effects;
D O I
暂无
中图分类号
学科分类号
摘要
Over the past several years, there have been a significant number of new agents developed for the treatment of type 2 diabetes. Our goal in this article is to review the cardiovascular effects (risks and benefits) of these oral and non-insulin injectable agents. We review six major categories of diabetic therapies: biguanides, sulfonylureas, alpha-glucosidase inhibitors, thiazolidinediones, GLP-1 agonists, and DPP-IV inhibitors. In order to achieve a personalized regimen that aims for optimal outcomes, we must take into consideration each drug’s side effects, patients’ cardiovascular risk factors, and their individual health profile.
引用
收藏
相关论文
共 50 条
  • [1] Cardiovascular Effects of Anti-Diabetic Medications in Type 2 Diabetes Mellitus
    Singh, Samar
    Bhat, Jyoti
    Wang, Ping H.
    [J]. CURRENT CARDIOLOGY REPORTS, 2013, 15 (01)
  • [2] Effect of Anti-Diabetic Medications on Fracture Risk in Type II Diabetes Mellitus
    Lahoud, Youmna
    Peloquin, Christine
    Zhang, Yuqing
    Misra, Devyani
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus
    Pretta, A.
    Pinna, G.
    Donisi, C.
    Persano, M.
    Cimbro, E.
    Parrino, A.
    Migliari, M.
    Dubois, M.
    Liscia, N.
    Mariani, S.
    Lai, E.
    Pusceddu, V.
    Puzzoni, M.
    Ziranu, P.
    Scartozzi, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S142 - S142
  • [4] Impact of Anti-Diabetic Medications on The Prevalence of Colorectal Neoplasm in Patients with Type2 Diabetes Mellitus
    Naravadi, Vishnu Vardhan Reddy
    Balasubramanian, Gokulakrishnan
    Pandit, Ananta
    Bavani, Nazli
    Dhroove, Gati
    Valluru, Neelima
    Molnar, Janos
    Anand, Kris
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S234 - S234
  • [5] The novel effects of anti-diabetic therapies on inflammatory mediators of type 2 diabetes mellitus
    Harte, Alison L.
    Al-Daghri, Nasser M.
    Alrubeaan, Khalid
    Al-Attas, Omar
    Da Silva, Nancy F.
    Sabico, Shaun L.
    McTernan, Philip G.
    Kumar, Sudhesh
    [J]. DIABETES, 2007, 56 : A147 - A147
  • [6] Anti-Diabetic Activity of Eugenol in Type-2 Diabetes Mellitus
    Garabadu, Debapriya
    Jasmine
    Krishnamurthy, Sairam
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S78 - S79
  • [7] Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
    Eleftheriadou, Ioanna
    Grigoropoulou, Pinelopi
    Liberopoulos, Evangelos
    Liatis, Stavros
    Kokkinos, Alexandros
    Tentolouris, Nikolaos
    [J]. CURRENT MEDICINAL CHEMISTRY, 2018, 25 (13) : 1549 - 1566
  • [8] Role of lifestyle and oral anti-diabetic agents to prevent type 2 diabetes mellitus and cardiovascular disease
    Bethel, M. Angelyn
    Califf, Robert M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05): : 726 - 731
  • [9] Influence of type 2 diabetes mellitus and concomitant anti-diabetic medications in patients with metastatic pancreatic ductal adenocarcinoma.
    Pretta, Andrea
    Cimbro, Erika
    Giampieri, Riccardo
    Spanu, Dario
    Lai, Eleonora
    Pecci, Federica
    Balconi, Francesca
    Lupi, Alessio
    Pozzari, Marta
    Murgia, Sara
    Bardanzellu, Fabio
    Maccioni, Antonio
    Contu, Fabiana
    Persano, Mara
    Donisi, Clelia
    Pusceddu, Valeria
    Puzzoni, Marco
    Ziranu, Pina
    Berardi, Rossana
    Scartozzi, Mario
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16301 - E16301
  • [10] Cardiovascular Safety of Medications for Type 2 Diabetes Mellitus
    Butler, Javed
    [J]. JOURNAL OF FAMILY PRACTICE, 2017, 66 (04): : S16 - S21